Peer review reports
From: Phase I dose-escalation oncology trials with sequential multiple schedules
Original Submission | ||
---|---|---|
25 Aug 2020 | Submitted | Original manuscript |
27 Aug 2020 | Author responded | Author comments - Burak Kürsad Günhan |
Resubmission - Version 2 | ||
27 Aug 2020 | Submitted | Manuscript version 2 |
29 Oct 2020 | Reviewed | Reviewer Report |
8 Dec 2020 | Reviewed | Reviewer Report |
8 Jan 2021 | Author responded | Author comments - Burak Kürsad Günhan |
Resubmission - Version 3 | ||
8 Jan 2021 | Submitted | Manuscript version 3 |
18 Jan 2021 | Reviewed | Reviewer Report |
22 Jan 2021 | Author responded | Author comments - Burak Kürsad Günhan |
Resubmission - Version 4 | ||
22 Jan 2021 | Submitted | Manuscript version 4 |
Publishing | ||
26 Jan 2021 | Editorially accepted | |
14 Apr 2021 | Article published | 10.1186/s12874-021-01218-9 |